How Do I Treat Low Gradient & Severe Aortic Stenosis?

Vinod Thourani

LAA Closure for Atrial Fibrillation using Occlusion Device

Congenital and Structural Interventions

H. Sievert

ESC 2024 Insights: SAVR and TAVI Comparison Across the Globe Based o…

ESC 2024 Insights

T. Doenst

The UPSTREAM Management of Aortic Stenosis in the Future

ARCH Advanced Revascularization Symposium

M. Leon

ACC 2023: Mitral Regurgitation - Five Diagnostic and Therapeutic Cha…

ACC 2023 Conference Coverage

G. W. Stone

Suprasternal Direct Aortic Approach TAVR Avoid Sternotomy and Thraco…

Miami Valves

A. Kiser

Percutaneous Mitral Paravalvular Leak Closure

Congenital and Structural Interventions

H. Sievert

[REMOVED] Clinically Proven Safe Outcomes - PINNACLE FLX Clinical Tr…

Boston Scientific

Valve Replacement for Pure Native Aortic Regurgitation from Alpha to…

Patrick Serruys

PARTNER 3 Trial: Should TAVR or SAVR Be Performed Among Low-risk Pat…

American College of Cardiology

D. Adams, V. Fuster, R. Mehran, A. Lala-Trindade, V. Reddy

Interview with Dr. Christopher Ellis: Left Atrial Appendage Manageme…

Georgia Heart Institute

D. Weisman, C. Ellis

CAD and Aortic Stenosis: Just Treat the Valve (Most of the Time)

ARCH Advanced Revascularization Symposium

M. Chung

My Most Valve-in-Valve: TAVR in TAVR

University of Miami

L. Cressa

A Story of a Left-Sided Bioprosthetic Valve Thrombosis

University of Miami

Z. Gunga

Stroke Prevention in Atrial Fibrillation

Penn Medicine Heart and Vascular Center

D. Goldberg

ACC 2023: Can LAAC Be Considered a True Alternative to OAC?

ACC 2023 Conference Coverage

A. Natale

TCT 2022: Transcatheter Edge-to-Edge Repair in Patients With Severe …

TCT 2022 Conference Coverage

M. Alkhouli

Improving Outcomes in Women with Valvular Heart Disease

Cedars Sinai

J. Chikwe

Evolution in the Treatment of Valvular Heart Disease: From Surgery t…

Gilbert Tang

The Future of TAVR - Where Will We Be In 2030? My Crystal Ball

University of Miami

E. Grube